Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction.

NCT00440258 is registered in ClinicalTrials.gov with Instituto Valenciano de Infertilidad, IVI VALENCIA as lead sponsor.

NCT NCT00440258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00440258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dopamine Agonist Cabergoline Reduces Hemoconcentration and Ascites in Hyperstimulated Women Undergoing Assisted Reproduction.
Lead sponsor
Instituto Valenciano de Infertilidad, IVI VALENCIA
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2004
Completion date
July 31, 2006
Enrollment
60
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

ovarian hyperstimulation syndrome